Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease. - Wikidata - awgldk - TriplyDB

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

http://www.wikidata.org/entity/Q43862601

about

Aberrant functional connectome in neurologically asymptomatic patients with end-stage renal disease Systematic review of structural and functional neuroimaging findings in children and adults with CKD.Multimodality MRI Findings in Patients with End-Stage Renal Disease.Altered pattern of spontaneous brain activity in the patients with end-stage renal disease: a resting-state functional MRI study with regional homogeneity analysis.Structural and functional brain alterations in end stage renal disease patients on routine hemodialysis: a voxel-based morphometry and resting state functional connectivity study.Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease.Design and methods of the NiCK study: neurocognitive assessment and magnetic resonance imaging analysis of children and young adults with chronic kidney disease.Spatial Disassociation of Disrupted Functional Connectivity for the Default Mode Network in Patients with End-Stage Renal Disease.Renal systems biology of patients with systemic inflammatory response syndrome Diffuse interstitial brain edema in patients with end-stage renal disease undergoing hemodialysis: a tract-based spatial statistics study.Evaluation of Neurocognition in Youth with CKD Using a Novel Computerized Neurocognitive Battery.Challenges in diagnosing hepatic encephalopathy.Chronic kidney disease-related physical frailty and cognitive impairment: a systemic review.Hemodialysis fatigue: just "simple" fatigue or a syndrome on its own right?Predominant gray matter volume loss in patients with end-stage renal disease: a voxel-based morphometry study.The relationship between putamen-SMA functional connectivity and sensorimotor abnormality in ESRD patients.

P2860

Q28544624-9F5CD153-25A5-4144-96E0-7CD61A43BDAD Q30636914-03BD09F4-6A4F-4D11-83BB-874C3EFA7A79 Q30969826-C0455E63-4E49-4F1A-96D7-1C83558DA5BD Q31131451-431A1252-8EDC-4CBC-A643-821503A7C35E Q33650581-DA59477A-8EA8-4256-8180-4AEA6EBC6D83 Q34146998-EF5157CF-8531-4152-A7F8-4F4A85503C44 Q35568910-DDEB83BA-39FF-4F34-86D3-95BACAAAFF6E Q36112676-BD92E1B1-5AAD-4BA3-B4EF-593F786F2039 Q36113202-F4CC32A4-53B8-4912-8EA5-15B6BA4FCE2C Q36153936-1930A767-40B1-4F50-A1C3-78245BFAAF00 Q36432853-5184CD70-3D01-47B0-A497-564ED95DF919 Q38241780-9F117014-89C3-49F6-AD42-FCBFC8F5D3A0 Q38848257-7A0E70CC-65A9-4954-8354-3B5738A47BE6 Q42100906-A8E0CEF8-6561-4F6F-A331-B2A7087D57C2 Q46549434-8221A17F-82AC-4853-9A64-7CF5F500C97B Q47918641-053057B5-DB7F-44BA-9D67-32BBA23F26C2

P2860

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

http://www.wikidata.org/entity/Q43862601

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

@en

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

@nl

type

label

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

@en

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

@nl

prefLabel

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

@en

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

@nl

P1433

Q43862601-DDA482EC-FAD7-47D5-933A-3ACBB92BDD45

P1476

Q43862601-4C689675-FFF7-45E9-AC42-21BAFC5EC2A2

P2093

Q43862601-19CE9025-EAAC-487C-A55F-D883AFE29C09

Q43862601-6D889A94-A414-42BB-9B8A-92D8C37040DD

Q43862601-74B94713-D916-4BB4-923E-0491708258BE

Q43862601-8C544A6F-9E3B-4ED2-93E2-4C575CA7F69F

Q43862601-BB51E694-5281-437F-B198-8DF0AF47F12B

Q43862601-C13084C9-15D8-4710-92B0-2CE6E09E63D1

Q43862601-E81CDFCF-CDEB-4624-8159-2F4B6D4728AE

P2860

Q43862601-00D9D956-21CB-472F-A6D4-93753F54C226

Q43862601-04CC79B5-C7F2-4C34-A88E-20E744FEA6C3

Q43862601-11D44892-78CF-4DDA-A89C-6F81D00A71B2

Q43862601-2431D8A7-BB53-4267-8F67-E8DF2AB4CDDB

Q43862601-3D46F4BF-9C2F-45D5-AB69-CCD7943E865F

Q43862601-51B976FA-BEA4-4237-80CA-7D14C1EC9D14

Q43862601-55EFF74F-A42B-43E9-AF56-98733DF82A4D

Q43862601-759C2C52-BC13-4034-8326-9B0E420C87BF

Q43862601-7DCE3270-4A3F-466B-AF65-68BB5F8878B9

Q43862601-8242BFD7-5FE8-4213-BD24-F897A3D98111

P304

Q43862601-9AC44A04-3682-456C-A25E-AE652C78105D

P31

Q43862601-B43B2795-D56B-4570-83AE-40592175F719

P356

Q43862601-22EA3F0E-09E3-47FF-98C5-93E1C3E684D4

P407

Q43862601-1C73F39B-9FFA-457D-9D98-9A3E7311241A

P433

Q43862601-C0CA33CA-742E-41B4-926C-B28F0765A465

P478

Q43862601-15B4C2CD-1294-49DC-B099-006EB9851D45

P577

Q43862601-59F81F76-838C-453D-8833-B15E97F6E16A

P5875

Q43862601-3DAC45CB-E472-4B51-AD13-DF72837D0C90

P698

Q43862601-66A6760F-C823-4898-A396-ABCDFDE9C3DF

P356

P1433

Nephrology Dialysis Transplantation

P1476

Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.

@en

P2093

Anita Blanka Tryc

http://www.w3.org/2001/XMLSchema#string

Annemarie Goldbecker

http://www.w3.org/2001/XMLSchema#string

Güldan Alwan

http://www.w3.org/2001/XMLSchema#string

Hartmut Hecker

http://www.w3.org/2001/XMLSchema#string

Karin Weissenborn

http://www.w3.org/2001/XMLSchema#string

Marion Haubitz

http://www.w3.org/2001/XMLSchema#string

Martin Bokemeyer

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates

Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Functional imaging of the brain in patients with liver cirrhosis.

Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.

Endogenous guanidino compounds as uremic neurotoxins.

Neurological complications in renal failure: a review.

Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy.

Automated single-voxel proton MRS: technical development and multisite verification.

Dialysis and transplantation affect cerebral abnormalities of end-stage renal disease.

P304

2635-2641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFQ729

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49738936

http://www.w3.org/2001/XMLSchema#string

P698

21216887

http://www.w3.org/2001/XMLSchema#string